Secondly, four small-molecule inhibitors (Idelalisib, Seletalisib, Wortmannin, and Dactolisib) were used to test the drug efficacies against the PCa cells expressing PIK3CD-L (encoding full-length PI3Kδ) and the PIK3CD-S splice variant. Here, PIK3CD is linked to posterior cortical atrophy.